Khanal Rajaram, Raj Bhattarai Shreeyash, Basnet Kriti, Shah Sangam, Dhital Roman, Kumar Sah Sanjit, Poudel Sujan, Frontela Odalys, Michel George, Marzban Sima, Rodriguez-Morales Alfonso J
Department of Cardiology, Manmohan Cardiothoracic Vascular and Transplant Center, Kathmandu, Nepal.
Division of Research and Academic Affairs, Larkin Community Hospital, South Miami, FL, USA.
Interdiscip Perspect Infect Dis. 2022 Jun 15;2022:9119930. doi: 10.1155/2022/9119930. eCollection 2022.
Patients infected with coronavirus disease 2019 (COVID-19) present with various clinical presentations with majority of them developing pulmonary complications. This study focuses on cardiac implications of COVID-19 which are less discussed and thus will help to address cardiac implications of COVID-19.
PubMed, PubMed Central, and Google Scholar were screened for articles which mentioned cardiac implications of COVID-19. NHLBI Study Quality Assessment Tools for the observational cohort and cross-sectional studies was used for assessing the risk of bias of our studies.
All 14 studies selected were good and had score of ≥9 by NHLBI Study Quality Assessment Tools. Cardiac complications of COVID-19 are common. They are associated with significant mortality. Also, people infected with COVID-19 with premorbid conditions such as cardiovascular diseases and diabetes mellitus have poor prognosis as compared to those without premorbid conditions. Cardiac biomarkers such as highly sensitive troponin I, creatinine, and creatinine kinase-MB on admission are good prognostic markers.
Cardiac complications such as heart failure, myocardial injury, and arrhythmias are common among patients infected with COVID-19. Elevated cardiac markers and patients with cardiac complications require utmost care and continuous cardiac monitoring.
2019冠状病毒病(COVID-19)感染患者临床表现各异,其中大多数会出现肺部并发症。本研究聚焦于COVID-19对心脏的影响,这方面讨论较少,因此有助于解决COVID-19对心脏的影响问题。
在PubMed、PubMed Central和谷歌学术上筛选提及COVID-19对心脏影响的文章。使用美国国立心肺血液研究所(NHLBI)观察性队列研究和横断面研究的研究质量评估工具来评估我们研究的偏倚风险。
所选的14项研究质量都很好,根据NHLBI研究质量评估工具得分均≥9分。COVID-19的心脏并发症很常见,与显著的死亡率相关。此外,与没有基础疾病的COVID-19感染者相比,患有心血管疾病和糖尿病等基础疾病的感染者预后较差。入院时的心脏生物标志物,如高敏肌钙蛋白I、肌酐和肌酸激酶同工酶MB是良好的预后指标。
心力衰竭、心肌损伤和心律失常等心脏并发症在COVID-19感染患者中很常见。心脏标志物升高的患者和有心脏并发症的患者需要格外护理和持续的心脏监测。